Lloyd A Rowland Cytom X Therapeutics, Inc. (CTMX) insider trading activity

Lloyd A Rowland is General Counsel of CytomX Therapeutics, Inc.. Currently has a direct ownership of 120,594 shares of CTMX, which is worth approximately $80,797. The most recent transaction as insider was on Mar 18, 2025, when has been sold 10,203 shares (Common Stock) at a price of $0.6 per share, resulting in proceeds of $6,121. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 121K

7.8% 3M change

2.43% 12M change

Total Value Held $80,797

LLOYD A ROWLAND Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 18 2025	SELL Open market or private sale	$6,121 $0.6 p/Share	10,203 Reduced 7.8%	120,594 Common Stock
Aug 20 2024	SELL Open market or private sale	$5,142 $1.23 p/Share	4,181 Reduced 3.1%	130,797 Common Stock
Aug 20 2024	BUY Exercise of conversion of derivative security	-	11,250 Added 7.69%	134,978 Common Stock
Mar 19 2024	SELL Open market or private sale	$11,010 $2.09 p/Share	5,268 Reduced 4.28%	117,728 Common Stock
Jan 18 2024	BUY Grant, award, or other acquisition	-	25,000 Added 16.89%	122,996 Common Stock
Dec 20 2023	SELL Open market or private sale	$5,626 $1.38 p/Share	4,077 Reduced 3.99%	97,996 Common Stock
Dec 17 2023	BUY Exercise of conversion of derivative security	-	11,250 Added 9.93%	102,073 Common Stock
Sep 22 2023	SELL Open market or private sale	$7,131 $1.3 p/Share	5,486 Reduced 6.37%	80,609 Common Stock
Sep 20 2023	BUY Grant, award, or other acquisition	-	15,000 Added 14.84%	86,095 Common Stock
Mar 16 2023	SELL Open market or private sale	$4,033 $1.98 p/Share	2,037 Reduced 2.79%	71,095 Common Stock
Feb 02 2023	BUY Grant, award, or other acquisition	-	25,000 Added 25.48%	73,132 Common Stock
Jul 20 2022	SELL Open market or private sale	$7,955 $1.42 p/Share	5,602 Reduced 11.37%	43,689 Common Stock
Jul 19 2022	BUY Grant, award, or other acquisition	-	15,000 Added 23.33%	49,291 Common Stock
Feb 02 2022	BUY Grant, award, or other acquisition	-	22,500 Added 39.62%	34,291 Common Stock

LAR

Lloyd A Rowland

General Counsel

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTMX shares.

Notify only if

Value

Insider Trading

Get notified when an Cytom X Therapeutics, Inc. insider buys or sells CTMX shares.

Notify only if

Operation

Value

Type

News

Receive news related to CytomX Therapeutics, Inc.

Track Activities on CTMX

Account